An Overview of Novel Therapies for Acute Hereditary Angioedema
- 1 December 2010
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 11 (6) , 383-388
Abstract
Hereditary angioedema is an episodic swelling disorder with autosomal dominant inheritance. Attacks are characterized by nonpitting edema of external or mucosal body surfaces. Patients often present with swelling of the extremities, abdominal pain, and swelling of the mouth and throat, which can at times lead to asphyxiation. The disease is caused by a mutation in the gene encoding the complement C1-inhibitor protein, which leads to unregulated production of bradykinin.Keywords
This publication has 35 references indexed in Scilit:
- Hereditary AngioedemaNew England Journal of Medicine, 2008
- Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type IIIThe American Journal of Human Genetics, 2006
- Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and CourseThe American Journal of Medicine, 2006
- Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary AngioedemaJournal of Allergy and Clinical Immunology, 2004
- Asphyxiation by Laryngeal Edema in Patients With Hereditary AngioedemaMayo Clinic Proceedings, 2000
- Clinical and biochemical effects of stanozolol therapy for hereditary angioedemaJournal of Allergy and Clinical Immunology, 1981
- Replacement Therapy in Hereditary AngioedemaNew England Journal of Medicine, 1980
- Effect of sex hormones on the complement‐related clinical disorder of hereditary angioedemaArthritis & Rheumatism, 1979
- Acquired inhibitor deficiency in lymphosarcomaClinical Immunology and Immunopathology, 1972
- Hereditary angioneurotic edemaJournal of Allergy, 1962